Rolf Breinbauer designs and synthesizes small‑molecule enzyme modulators, integrating biophysical and structural analysis to clarify mechanism and selectivity. Work spans natural‑product‑inspired scaffolds, peptidomimetics, and lipase/protease inhibitors, with applications in metabolic and infectious disease.